The upcoming report from CareDx (CDNA) is expected to reveal quarterly loss of $0.19 per share, indicating a decline of 72.7% compared to the year-ago period. Analysts forecast revenues of $63.63 ...

Does the February share price for CareDx, Inc (NASDAQ:CDNA) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by projecting its future cash flows and then discounting ...

This article first appeared on GuruFocus. CareDx Inc (NASDAQ:CDNA) is set to release its Q3 2025 earnings on Nov 4, 2025. The consensus estimate for Q3 2025 revenue is $95.25 million, and the earnings ...

CareDx (CDNA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

Total Revenue: $100.1 million, up 21% year over year. Testing Services Revenue: $72.2 million, an increase of 19% year over year. Patient and Digital Solutions Revenue: $15.4 million, up 30% year over ...

Craig-Hallum analyst Alexander Nowak maintained a Hold rating on CareDx (CDNA – Research Report) today. The company’s shares closed yesterday at $9.64. Nowak covers the Healthcare sector, focusing on ...

CareDx, Inc. (NASDAQ:CDNA) faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions ...

CareDx (CDNA) has flipped to profitability for the first time, with net profit margins turning positive and earnings now forecast to soar 80.2% per year. This growth rate far outpaces the company’s ...

CareDx (CDNA) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.14 per share a year ago. These figures are ...